Barclays
NBP icon

Barclays’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Barclays’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.9K Sell
10,198
-268,821
-96% -$472K ﹤0.01% 4795
2026
Q2 		$544K Sell
279,019
-20,280
-7% -$41.4K ﹤0.01% 3164
2026
Q1 		$736K Sell
299,299
-329,624
-52% -$1.1M ﹤0.01% 2945
2025
Q4 		$2.5M Buy
628,923
+233,492
+59% +$1.03M ﹤0.01% 2775
2025
Q3 		$1.49M Buy
395,431
+365,061
+1,202% +$1.24M ﹤0.01% 3104
2025
Q2 		$73.5K Hold
30,370
– – ﹤0.01% 4644
2025
Q1 		$25K Hold
30,370
– – ﹤0.01% 4754
2024
Q4 		$25.8K Hold
30,370
– – ﹤0.01% 4883
2024
Q3 		$37.7K Hold
30,370
– – ﹤0.01% 4804
2024
Q2 		$50.7K Sell
30,370
-8,182
-21% -$14.6K ﹤0.01% 4209
2024
Q1 		$71.7K Sell
38,552
-134,512
-78% -$248K ﹤0.01% 4538
2023
Q4 		$329K Buy
173,064
+60,597
+54% +$90.5K ﹤0.01% 4150
2023
Q3 		$148K Hold
112,467
– – ﹤0.01% 3426
2023
Q2 		$336K Sell
112,467
-317,939
-74% -$1.02M ﹤0.01% 2988
2023
Q1 		$1.49M Buy
430,406
+101,106
+31% +$490K ﹤0.01% 2427
2022
Q4 		$1.38M Buy
+329,300
New +$1.25M ﹤0.01% 2546
2022
Q2 		– Sell
-240,881
Closed -$3.91M – 5139
2022
Q1 		$3.91M Buy
+240,881
New +$6.17M ﹤0.01% 1379

Other funds holding NBP

Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nations Financial Group
Nations Financial Group Cedar Rapids, Iowa $2.01B AUM 24.56% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57.1B AUM 43.46% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
GF Fund Management
GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Barclays's NBP Position: Q3 2026 in Review

Barclays reduced its NovaBridge Biosciences American Depositary Shares (NBP) stake by 96% in Q3 2026, selling an estimated $472K and leaving 10,198 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4795.

Barclays first reported a position in NBP in Q1 2022 and has held it in 17 quarters since. The position peaked at $3.91M in Q1 2022. 13 funds tracked by Wall St. Rank hold NBP as of Q3 2026.

  • Barclays held 10,198 shares of NovaBridge Biosciences American Depositary Shares worth $13.9K as of Q3 2026.
  • Barclays sold 268,821 NovaBridge Biosciences American Depositary Shares shares in Q3 2026, an estimated $472K.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4795 holding.
  • Barclays first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2022 and has held it in 17 quarters since.
  • Barclays's NovaBridge Biosciences American Depositary Shares position peaked at $3.91M in Q1 2022.
  • 13 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.